Connect with us

Legal & Regulation

FDA Still Unsettled About CBD, Cites Dosing Amounts and Medical Interactions as Biggest Questions

Lin YC

Published

on

FDA Still Unsettled About CBD, Cites Dosing Amounts and Medical Interactions as Biggest Questions
- Ad -

Dr. Amy Abernethy and Lowell Schiller of the FDA are part of a work group tasked with determining the impact of cannabinoids in food, drugs, and dietary supplements. The conclusions are meant to help the FDA develop a policy concerning CBD in food and dietary supplements.

At this point, there are four outstanding health questions that Dr. Abernethy and Lowell list in the first statement they released. They are looking to know more about:

  1. the safe levels of CBD consumption.
  2. the interaction between CBD and other drugs.
  3. the affect of CBD on populations such as children, the elderly, pregnant, and lactating women.
  4. the risk of long-term CBD use.

According to Dr. Abernethy and Lowell, the FDA is “committed to evaluating the regulatory frameworks for nondrug uses, including products marketed as foods and dietary supplements.”

The full statement can be read on here: FDA CBD statement

Lin YC is known as a magnetic mama and brings a wide array of skillsets, knowledge and entertainment to the TOC team. With a Bachelor’s Degree in Philosophy, from her college student starting blocks as a writer to now being featured on LiveStrong, TheNest, eHow, Leaf.tv and Synonym.com, Lin is a true talent for specializing in health, beauty, fitness, weight loss and alternative medicines such as hemp.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com